GILD News 105.39 09/24/2014 05:01:01 Gilead Sciences (GILD)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gilead Sciences (GILD) 105.39 $GILD

Gilead Submits New Drug Application to Japan's Pharmaceutical and Medical Devices Agency for Fixed-Dose Combination of Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 1 Infection
Business Wire - Tue Sep 23, 11:00PM CDT
-- Ledipasvir/Sofosbuvir Simplifies Hepatitis C Treatment to a Single, Once-Daily Tablet --

Final Glance: Biotechnology companies
AP - Tue Sep 23, 5:03PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:

Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 4:55PM CDT
Amgen (AMGN) announced that it has submitted a Biologics License Application to the FDA for blinatumomab.

AstraZeneca Posts Positive Data on its Type II Diabetes Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 4:20PM CDT
AstraZeneca (AZN) announced encouraging data from the phase III DURATION-NEO-1 study.

Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 3:45PM CDT
Bayer (BAYRY) announced that its blockbuster eye treatment, Eylea, was approved for yet another indication in Japan.

Integra Freedom Wrist's Commercial Availability Falls Flat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 2:10PM CDT
Initially after the news release, Integra LifeSciences' (IART) share price had risen 0.5%. However, the launch failed to sustain this positive price momentum, with shares eventually dropping 0.6% to close at $49.97 yesterday.

Midday Glance: Biotechnology companies
AP - Tue Sep 23, 12:20PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:

Early Glance: Biotechnology companies
AP - Tue Sep 23, 9:29AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:

OncoMed Pharmaceuticals (OMED) Jumps: Stock Up 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Sep 23, 7:51AM CDT
OncoMed Pharmaceuticals, Inc. (OMED) was a big mover last session, as its shares rose over 5% on the day.

Most Big Cap 20 Stocks Near Entries, But Risks Exist
at Investor's Business Daily - Mon Sep 22, 6:05PM CDT
Most of the Big Cap 20 stocks are in buy ranges or forming bases. That's an unusually good trend that affords investors plenty of opportunities to deploy capital. But a sluggish market poses risks for any new purchases. For those willing to risk...

Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 4:45PM CDT
GlaxoSmithKline (GSK) announced that it has been found guilty of bribing non-government personnel by the Changsha Intermediate People's Court in Hunan Province, China.

Isis Pharmaceuticals Up on $4M Milestone Payment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 4:40PM CDT
Isis Pharmaceuticals, Inc. (ISIS) earned a $4 million milestone payment from Achaogen (AKAO), following the initiation of a phase III study on plazomicin.

Gilead's (GILD) Zydelig Gets EU Clearance for Blood Cancer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 4:20PM CDT
The European Commission has approved Gilead's (GILD) Zydelig for the treatment of CLL and FL.

Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 2:59PM CDT
Flexion announced that the FDA has placed a clinical hold on patient enrollment and dosing in an ongoing phase IIb study on FX006.

Surprising Silver Lining for Gilead Sciences, inc. Stock
Brian Orelli, The Motley Fool - Motley Fool - Mon Sep 22, 2:37PM CDT
Shares of Gilead Sciences got knocked down last week after CVS Health released data showing higher discontinuation rates for hepatitis C patients taking Sovaldi than Gilead Sciences saw in its clinical trials. Source: Gilead Sciences ...

Gilead Sciences (GILD) Crosses Pivot Point Support at $105.02
Comtex SmarTrend(R) - Mon Sep 22, 12:27PM CDT
Gilead Sciences (NASDAQ:GILD) has opened bearishly below the pivot of $106.45 today and has reached the first level of support at $105.02. Investors may be interested in a cross of the next downside pivot targets of $104.07 and $101.69.

Gilead Sciences: A Preview of Important HIV Drug Study Results
at The Street - Mon Sep 22, 11:44AM CDT
Gilead's goal is to create new versions of its blockbuster HIV combination therapies, replacing Viread with TAF.

Dynavax (DVAX) Jumps: Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:46AM CDT
Dynavax (DVAX) was a big mover last session, with shares rising nearly 7% on the day.

Cytori Therapeutics (CYTX) Jumps: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:39AM CDT
Cytori Therapeutics, Inc. (CYTX) was a big mover last session, as its shares rose over 6% on the day.

Licensing Agreements, Results of Clinical Trials, and Acquisitions - Research Reports on Gilead, AbbVie, Pfizer, Auxilium and Endo
PR Newswire - Mon Sep 22, 8:05AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), AbbVie Inc. (NYSE: ABBV), Pfizer Inc. (NYSE: PFE), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL) and Endo International plc (NASDAQ: ENDP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6643-100free.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SAGA's Radar Assays Tighten the Trapper North Case

Updated Category News Views 22

Rock that keeps showing up where the model says it should is the sort of boring news a junior miner desperately needs. SAGA Metals has put out fresh assay results from Radar’s Trapper North area, and the useful part is not merely a loud grade in one hole. It is the apparent persistence of thick titanium-vanadium-iron oxide mineralization across tighter-spaced drilling....

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 20

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
Yoodli's No. 9 Ranking Signals Enterprise AI Traction

Updated Category News Views 0

Ninth place can be easy to dismiss until you notice the company is sitting near the top of a 500-name growth list. Yoodli's No. 9 position on Deloitte's 2026 Technology Fast 500 is a meaningful signal that its AI-based coaching and workforce-skills pitch is getting traction inside large organizations. It is not a revenue disclosure, it is not a valuation marker, and...

Continue Reading
Workday’s EU Cloud Move Raises the Sovereignty Bar Again

Updated Category News Views 60

Europe’s sovereignty squeeze just got a lot more concrete for Workday. The company is taking its EU Sovereign Cloud beyond the usual data-residency talking points by planning an Ireland-based operating company, European leadership, and governance intended to keep decisions on the service and customer data inside Europe. For a platform sitting underneath payroll, HR...

Continue Reading
Halff Elevates People and Delivery Leadership Team

Updated Category News Views 78

Infrastructure outfits rarely make much noise when they reshuffle leadership, but Halff’s Nov. 18 announcement deserves a closer look than the usual executive-title confetti. The employee-owned consulting firm has put Greg Carpenter in the chief people officer seat and named Leigh Hollis chief delivery officer. One role is aimed squarely at the human machinery; the...

Continue Reading
LASIK Cost Math Deserves a Careful Second Look Today

Updated Category News Views 204

Thirty years of lens purchases can become a nasty tab Contact-lens spending has a funny way of staying invisible until somebody stacks the receipts into one ugly pile. A new cost-of-vision analysis from the surgeon advisory board of BestLASIKSurgeons.com says the average American contact-lens wearer may spend between $22,500 and $30,000 on corrective eyewear across 30...

Continue Reading
Clorox Boosts Payout With Steady $1.25 Dividend

Updated Category News Views 221

Quarterly Dividends: A Clorox Tradition It seems you can't talk about Clorox (NYSE: CLX) without mentioning its steadfast dedication to shareholders. Once again, this 113-year-old stalwart is back on the map with its juicy quarterly dividend—$1.25 per share, to be precise. That's scheduled to hit your account by February 12, 2027, if you're on the books by the end of...

Continue Reading
Teachers in Space Takes Its Classroom Model Orbital

Updated Category News Views 0

Two teachers strapped into a research flight may sound like a glossy space-age photo op, but the useful part of this plan sits back in the classroom with the students staring at the data. Teachers in Space wants to send two educators aboard a Virgin Galactic research flight expected in 2027, and it is raising $2 million to fund the broader educational program and mission....

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 46

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
ActivTrak's Fast 500 Rank Needs Investor Perspective

Updated Category News Views 27

Rank 488 is the sort of trophy that deserves a raised eyebrow, not confetti. ActivTrak made Deloitte's 2026 Technology Fast 500 after posting 101.1% revenue growth from 2022 through 2025, its sixth appearance on the list since 2020. That is real progress, and repeat recognition says this was not a one-quarter sugar high. Still, a Fast 500 ranking is a growth screen, not a...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring AML's Innovative Permanent Magnet Manufacturing

Updated Category News Views 246

Revolutionizing Permanent Magnet Production Advanced Magnet Lab, Inc. (AML) has emerged as a frontrunner in the field of innovative magnet technologies. By harnessing their advanced PM-Wire™ manufacturing process, AML is setting the stage for a broad range of applications that require permanent magnets. This new technology opens avenues for diverse supply chain...

Continue Reading
Harmonic Secures $75 Million Funding to Innovate AI Mathematics

Updated Category News Views 475

Harmonic Secures $75 Million in Series A Funding Harmonic, a Palo Alto-based innovator in artificial intelligence, has just revealed that it successfully raised $75 million in a Series A funding round. This investment values the company at $325 million, led by the well-known venture capital firm Sequoia Capital, alongside significant backing from Index Ventures and...

Continue Reading
Peoria's Mercedes-Benz of Arrowhead Offers Luxury 3-Row SUVs

Updated Category News Views 22

Luxury SUVs with Space and Sophistication When it comes to racking up the mileage in style, finding that sweet spot between luxury and practicality is the holy grail for many car buyers. Right in the heart of Peoria, Arizona, Mercedes-Benz of Arrowhead is rolling out a red carpet for those of us who crave both opulence and utility in one sleek package. Why Third-Row...

Continue Reading
Understanding the Rise in Comfort Systems USA's Short Interest

Updated Category News Views 176

Understanding Comfort Systems USA's Short Interest The short interest of Comfort Systems USA (NYSE: FIX) has seen a notable rise, increasing by 40.65% since the last report. This reflects growing concerns or speculation surrounding the company's stock performance. Currently, approximately 536 thousand shares are sold short, which constitutes 2.18% of the total shares...

Continue Reading
Investigating Today's Top 5 Stocks: Trends and Insights

Updated Category News Views 181

Market Overview Stocks in the U.S. presented a mixed picture recently, with notable fluctuations in the major indexes. The Dow Jones Industrial Average saw a slight dip of 0.1%, closing at 44,837.56, while the S&P 500 remained stable at 6,389.77. Meanwhile, the Nasdaq climbed slightly, gaining 0.3% to end the day at 21,178.58. Top Five Stocks to Watch Today Market...

Continue Reading